CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise Chief Medical Officer acquired 45,000 shares (option exercise)
- 8-K Event Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 3,846 shares at $26.08 ($100,304)
- 8-K Event Regulation FD disclosure · Other events
- 4 Option exercise Principal Accounting Officer acquired 12,218 shares (option exercise)
- 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
- 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 4 Conversion 10% owner acquired 2,442,080 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 20,604 shares (conversion)
- 4 Conversion Director acquired 2,689,329 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
Page 24 of 26 · 514 filings